Khalid Ibrahim Al-Shibli

Khalid Ibrahim Al-Shibli is an Associate Professor in the Department of Clinical Medicine at UiT The Arctic University of Norway in Tromsø. His academic work focuses on cancer research with particular emphasis on lung and cervical cancers, where he has established himself as a prominent researcher through numerous publications and collaborations.

Dr. Al-Shibli's research interests center on tumor immunology, biomarker discovery, and cancer prognostics. His work extensively examines the relationship between immune cell infiltration in tumors and patient outcomes, with particular focus on non-small cell lung cancer (NSCLC). He investigates how various molecular markers, including microRNAs, chemokines, and immune cell populations, correlate with cancer progression and survival rates. His research spans both basic science investigations into tumor microenvironment mechanisms and translational studies aimed at improving clinical cancer diagnostics and treatment.

Analysis of Dr. Al-Shibli's publication record reveals a consistent trajectory of high-impact research in oncology, particularly in tumor immunology and biomarker discovery. His work demonstrates a strong collaborative approach, frequently working with researchers at UiT and other Norwegian institutions. The research shows evolution from basic biomarker identification to more complex studies examining the clinical implementation of immunoscore systems and precision medicine approaches in cancer care.

While specific details about his teaching responsibilities are not provided in the available information, his position as Associate Professor indicates significant involvement in medical education at UiT. His research collaborations suggest active participation in multi-institutional projects focused on improving cancer diagnostics and treatment in the Norwegian healthcare system.